Another J&J plant in Pa. under scrutiny

July 20, 2010 5:29:52 AM PDT
Another Johnson & Johnson medicine factory is under scrutiny from federal regulators.

The healthcare giant in April shut down a suburban Philadelphia plant that's now linked to eight recalls of Tylenol and other nonprescription drugs for children and adults.

Now the Food and Drug Administration has filed a critical report after a recent inspection found problems at another Pennsylvania plant, in Lancaster.

J&J says it's addressing FDA's concerns as quickly as possible.

The plant is operated by a joint venture called Johnson & Johnson/Merck Consumer Pharmaceuticals. The business sells products including heartburn medicines Mylanta and Pepcid.

An FDA spokeswoman says the report is still under review and cannot be released yet.